Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Market growth in personalized medicine is being driven by demand, involving major players like Roche and Illumina.Sub-event
Five companies are major players in the US personalized medicine market.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Abbott Laboratories
American global health care and medical device products company
-
Qiagen
company
Nothing else this week.
Related events
- AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.
- Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.
- AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
Coverage
Newest first; wire copies grouped- GlobeNewswireUS Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche The United